Jazz Pharmaceuticals (JAZZ) Non Operating Income (2015 - 2017)

Jazz Pharmaceuticals' Non Operating Income history runs 3 years deep, the most recent figure standing at -$1.5 million for Q1 2017.

• In Q1 2017, Non Operating Income fell 78.75% year-over-year to -$1.5 million; the TTM figure through Mar 2017 stood at -$3.0 million (down 87.28% YoY), while the FY2015 annual figure was $1.4 million, down 83.36% from the prior year.
• Non Operating Income was -$1.5 million for Q1 2017 at Jazz Pharmaceuticals, down from -$749000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $2.2 million in Q1 2015 to a low of -$1.9 million in Q2 2015.
• Historically, Non Operating Income has averaged -$226714.3 across 3 years, with a median of -$819000.0 in 2016.
• Biggest YoY gain for Non Operating Income was 23.34% in 2016; the steepest drop was 136.48% in 2016.
• A 3-year view of Non Operating Income shows it stood at $2.1 million in 2015, then sank by 135.82% to -$749000.0 in 2016, then plunged by 95.46% to -$1.5 million in 2017.
• The last three Non Operating Income figures came in at -$1.5 million (Q1 2017), -$749000.0 (Q3 2016), and -$819000.0 (Q1 2016), per Business Quant data.